球囊肺动脉成形术治疗不可手术慢性血栓栓塞性肺动脉高压的长期疗效与安全性综合评价
该研究纳入84例不可手术的慢性血栓栓塞性肺动脉高压患者,共实施424次球囊肺动脉成形术(BPA)。77例完成治疗的患者在末次BPA后6个月及慢性期(首次BPA后>12个月)血流动力学和运动能力显著改善并持续,5年生存率98.4%,无围手术期死亡。
要点
- BPA可显著改善不可手术CTEPH患者的血流动力学和运动能力。
- BPA的获益在长期随访中持续存在。
- BPA围手术期并发症可接受,5年生存率高。
核心结论
- BPA改善不可手术CTEPH患者的血流动力学和运动能力,并发症率可接受,血流动力学获益持续数年,长期预后良好。
研究设计与样本
- 单中心回顾性研究,纳入2009年7月至2016年10月连续84例不可手术CTEPH患者,共实施424次BPA。
- 77例(92%)完成BPA治疗的患者纳入分析,年龄65±14岁,男性14例、女性63例。
主要发现
- BPA治疗后平均肺动脉压从38±10 mmHg降至25±6 mmHg,肺血管阻力从7.3±3.2 Wood单位降至3.8±1.0 Wood单位,6分钟步行距离从380±138 m增至486±112 m(均P<0.01)。
- 在随访43±27个月(N=53)期间,上述改善持续存在。
- 424次BPA中,咯血发生60次(14%),使用无创正压通气治疗咯血和/或低氧血症33次(8%)。
- 5年生存率为98.4%(仅1例死于结肠癌),无围手术期死亡。
临床怎么用
- 对于不可手术的CTEPH患者,BPA可作为一种改善血流动力学和运动能力的治疗选择。
- BPA治疗中需关注咯血和低氧血症等并发症,必要时使用无创正压通气支持。
局限性
- 本研究为单中心回顾性研究,样本量有限(84例),结果需在更广泛人群中验证。
- 部分患者(7例)未完成BPA治疗,可能影响结果代表性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Although balloon pulmonary angioplasty (BPA) improves haemodynamics and short-term prognosis in patients with inoperable chronic thrombo-embolic pulmonary hypertension (CTEPH), the long-term effects of BPA, and procedure-related complications remain to be fully elucidated. METHODS AND RESULTS: From July 2009 to October 2016, we performed a total of 424 BPA sessions in 84 consecutive patients with inoperable CTEPH. We used 3D reconstructed computed tomography to determine target lesions of pulmonary arteries and optical computed tomography to select balloon size, if needed. In 77 patients (92%) who completed the BPA treatment [65 ± 14 (SD) years-old, male/female 14/63], haemodynamics and exercise capacity were examined at 6 months after last BPA and in the chronic phase [>12 months after first BPA, 31 (20, 41) months]. The BPA treatment significantly improved mean pulmonary arterial pressure (38 ± 10 to 25 ± 6 mmHg), pulmonary vascular resistance (7.3 ± 3.2 to 3.8 ± 1.0 Wood units), and 6-minute walk distance (380 ± 138 to 486 ± 112 m) (all P < 0.01), and the improvements persisted throughout the follow-up period (43 ± 27 months) (N = 53). In the 424 sessions, haemoptysis was noted in 60 sessions (14%), and non-invasive positive pressure ventilation (NPPV) was used to treat haemoptysis and/or hypoxemia in 33 sessions (8%). Furthermore, 5-year survival was 98.4% (only one patient died of colon cancer) with no peri-procedural death. CONCLUSION: These results indicate that BPA improves haemodynamics and exercise capacity in inoperable CTEPH patients with acceptable complication rate and that the beneficial haemodynamic effects of BPA persist for years with resultant good long-term prognosis.
引用
- Aoki T, Sugimura K, Tatebe S, et al. Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications. Eur Heart J. 2017. PMID: 29029023. doi:10.1093/eurheartj/ehx530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。